Table 5 Mean and median adherence rates and proportion with adherence ≥0.80 for patients on polytherapy (n = 777)
From: Measuring medication adherence in patients with incident hypertension: a retrospective cohort study
|  | Range | Mean (SD) | Median (IQR) | Proportion ≥0.80 | |||
|---|---|---|---|---|---|---|---|
Overall | MPRi | Low | 0.01–1.00 | 0.47 (0.32) | 0.41 (0.16, 0.77) | 24.1% | |
High | 0.15–1.00 | 0.84 (0.21) | 0.93 (0.74, 0.99) | 69.6% | |||
Sum | 0.25–1.00 | 0.95 (0.13) | 1.00 (1.00, 1.00) | 90.5% | |||
Mean | 0.11–1.00 | 0.66 (0.23) | 0.64 (0.49, 0.87) | 33.7% | |||
MPRp | Low | 0.05–1.00 | 0.84 (0.21) | 0.92 (0.77, 0.99) | 71.2% | ||
High | 0.10–1.00 | 0.94 (0.13) | 1.00 (0.94, 1.00) | 89.5% | |||
Sum | 0.16–1.00 | 0.96 (0.12) | 1.00 (1.00, 1.00) | 92.7% | |||
Mean | 0.10–1.00 | 0.89 (0.15) | 0.95 (0.84, 0.99) | 81.0% | |||
PDC |  | 0.15–1.00 | 0.90 (0.18) | 0.98 (0.90, 1.00) | 83.0% | ||
Age | 65 to 74 years | MPRi | Low | 0.01–1.00 | 0.50 (0.32) | 0.48 (0.19, 0.82) | 25.2% |
High | 0.16–1.00 | 0.85 (0.19) | 0.92 (0.79, 0.99) | 73.5% | |||
Sum | 0.33–1.00 | 0.97 (0.11) | 1.00 (1.00, 1.00) | 93.2% | |||
Mean | 0.11–1.00 | 0.67 (0.23) | 0.69 (0.49, 0.88) | 37.2% | |||
MPRp | Low | 0.05–1.00 | 0.83 (0.22) | 0.91 (0.78, 0.98) | 71.8% | ||
High | 0.10–1.00 | 0.93 (0.15) | 1.00 (0.94, 1.00) | 89.7% | |||
Sum | 0.20–1.00 | 0.96 (0.12) | 1.00 (1.00, 1.00) | 92.7% | |||
Mean | 0.10–1.00 | 0.88 (0.17) | 0.94 (0.84, 0.99) | 82.5% | |||
PDC | 0.16–1.00 | 0.91 (0.16) | 0.98 (0.91, 1.00) | 85.9% | |||
75 years and over | MPRi | Low | 0.01–1.00 | 0.46 (0.33) | 0.39 (0.16, 0.76) | 23.6% | |
High | 0.15–1.00 | 0.83 (0.21) | 0.94 (0.74, 0.99) | 68.0% | |||
Sum | 0.25–1.00 | 0.95 (0.14) | 1.00 (1.00, 1.00) | 89.3% | |||
Mean | 0.11–1.00 | 0.65 (0.23) | 0.63 (0.48, 0.87) | 32.2% | |||
MPRp | Low | 0.08–1.00 | 0.84 (0.21) | 0.93 (0.77, 0.99) | 70.9% | ||
High | 0.20–1.00 | 0.94 (0.12) | 1.00 (0.94, 1.00) | 89.4% | |||
Sum | 0.16–1.00 | 0.96 (0.11) | 1.00 (1.00, 1.00) | 92.6% | |||
Mean | 0.15–1.00 | 0.89 (0.15) | 0.96 (0.85, 0.99) | 80.3% | |||
PDC | 0.15–1.00 | 0.89 (0.19) | 0.99 (0.88, 1.00) | 81.8% | |||
Sex | Male | MPRi | Low | 0.01–1.00 | 0.50 (0.33) | 0.44 (0.16, 0.82) | 26.2% |
High | 0.15–1.00 | 0.83 (0.22) | 0.93 (0.74, 0.99) | 69.2% | |||
Sum | 0.25–1.00 | 0.94 (0.15) | 1.00 (1.00, 1.00) | 89.1% | |||
Mean | 0.11–1.00 | 0.66 (0.24) | 0.67 (0.48, 0.88) | 36.6% | |||
MPRp | Low | 0.05–1.00 | 0.83 (0.22) | 0.92 (0.78, 0.98) | 70.5% | ||
High | 0.18–1.00 | 0.93 (0.14) | 0.99 (0.93, 1.0) | 90.8% | |||
Sum | 0.16–1.00 | 0.96 (0.13) | 1.00 (1.00, 1.00) | 91.9% | |||
Mean | 0.15–1.00 | 0.88 (0.16) | 0.95 (0.84, 0.99) | 80.9% | |||
PDC | 0.15–1.00 | 0.88 (0.20) | 0.98 (0.85, 1.00) | 80.4% | |||
Female | MPRi | Low | 0.01–1.00 | 0.45 (0.32) | 0.38 (0.16, 0.74) | 22.3% | |
High | 0.16–1.00 | 0.84 (0.19) | 0.94 (0.75, 0.99) | 70.0% | |||
Sum | 0.33–1.00 | 0.96 (0.12) | 1.00 (1.00, 1.00) | 91.6% | |||
Mean | 0.11–1.00 | 0.65 (0.22) | 0.63 (0.49, 0.86) | 31.4% | |||
MPRp | Low | 0.10–1.00 | 0.84 (0.20) | 0.93 (0.77, 0.99) | 71.7% | ||
High | 0.10–1.00 | 0.94 (0.13) | 1.00 (0.95, 1.00) | 88.5% | |||
Sum | 0.20–1.00 | 0.97 (0.10) | 1.00 (1.00, 1.00) | 93.3% | |||
Mean | 0.10–1.00 | 0.89 (0.15) | 0.95 (0.85, 0.99) | 81.0% | |||
PDC | 0.16–1.00 | 0.91 (0.16) | 0.99 (0.91, 1.00) | 85.1% | |||
Income | Lowest quintile | MPRi | Low | 0.01–1.00 | 0.47 (0.31) | 0.42 (0.16, 0.75) | 20.1% |
High | 0.16–1.00 | 0.83 (0.21) | 0.93 (0.74, 0.99) | 66.9% | |||
Sum | 0.33–1.00 | 0.95 (0.14) | 1.00 (1.00, 1.00) | 90.7% | |||
Mean | 0. 11–1.00 | 0.65 (0.23) | 0.63 (0.46, 0.86) | 35.3% | |||
MPRp | Low | 0.10–1.00 | 0.79 (0.24) | 0.89 (0.68, 0.99) | 61.6% | ||
High | 0.10–1.00 | 0.92 (0.16) | 1.00 (0.91, 1.00) | 85.5% | |||
Sum | 0.16–1.00 | 0.94 (0.15) | 1.00 (1.00, 1.00) | 88.5% | |||
Mean | 0.10–1.00 | 0.86 (0.18) | 0.92 (0.80, 0.99) | 74.6% | |||
PDC | 0.16–1.00 | 0.88 (0.19) | 0.98 (0.84, 1.00) | 79.1% | |||
Highest quintile | MPRi | Low | 0.01–1.00 | 0.47 (0.32) | 0.40 (0.16, 0.79) | 24.6% | |
High | 0.19–1.00 | 0.83 (0.20) | 0.93 (0.69, 0.99) | 67.5% | |||
Sum | 0.36–1.00 | 0.95 (0.12) | 1.00 (1.00, 1.00) | 90.5% | |||
Mean | 0. 12–1.00 | 0.65 (0.23) | 0.63 (0.49, 0.88) | 31.8% | |||
MPRp | Low | 0.14–1.00 | 0.87 (0.17) | 0.94 (0.81, 0.99) | 77.6% | ||
High | 0.42–1.00 | 0.94 (0.11) | 1.00 (0.95, 1.00) | 92.0% | |||
Sum | 0.35–1.00 | 0.96 (0.11) | 1.00 (1.00, 1.00) | 92.9% | |||
Mean | 0.31–1.00 | 0.91 (0.13) | 0.96 (0.87, 0.99) | 86.4% | |||
PDC | 0.19–1.00 | 0.91 (0.17) | 0.99 (0.92, 0.99) | 86.5% | |||
Charlson comorbidities | 0 or 1 comorbidities | MPRi | Low | 0.01–1.00 | 0.46 (0.32) | 0.41 (0.16, 0.76) | 23.1% |
High | 0.15–1.00 | 0.83 (0.21) | 0.93 (0.74, 0.99) | 69.1% | |||
Sum | 0.25–1.00 | 0.95 (0.14) | 1.00 (1.00, 1.00) | 90.2% | |||
Mean | 0.11–1.00 | 0.65 (0.23) | 0.63 (0.48, 0.87) | 32.3% | |||
MPRp | Low | 0.05–1.00 | 0.83 (0.21) | 0.92 (0.77, 0.99) | 71.1% | ||
High | 0.10–1.00 | 0.94 (0.13) | 1.00 (0.94, 1.00) | 89.5% | |||
Sum | 0.16–1.00 | 0.96 (0.12) | 1.00 (1.00, 1.00) | 92.7% | |||
Mean | 0.10–1.00 | 0.89 (0.16) | 0.95 (0.84, 0.99) | 80.5% | |||
PDC | 0.15–1.00 | 0.90 (0.18) | 0.98 (0.90, 1.00) | 83.1% | |||
2+ comorbidities | MPRi | Low | 0.05–1.00 | 0.54 (0.34) | 0.57 (0.16, 0.85) | 33.3% | |
|  | High | 0.25–1.00 | 0.86 (0.19) | 0.96 (0.80, 1.00) | 74.7% | ||
|  | Sum | 0.41–1.00 | 0.97 (0.10) | 1.00 (1.00, 1.00) | 93.3% | ||
|  | Mean | 0.11–1.00 | 0.71 (0.24) | 0.76 (0.51, 0.92) | 46.7% | ||
MPRp | Low | 0.08–1.00 | 0.85 (0.19) | 0.93 (0.75, 0.99) | 72.0% | ||
High | 0.48–1.00 | 0.94 (0.12) | 1.00 (0.96, 1.00) | 89.3% | |||
Sum | 0.53–1.00 | 0.97 (0.09) | 1.00 (1.00, 1.00) | 92.0% | |||
Mean | 0.36–1.00 | 0.90 (0.13) | 0.95 (0.85, 0.99) | 85.3% | |||
PDC | 0.25–1.00 | 0.91 (0.15) | 0.99 (0.88, 1.00) | 82.7% | |||